2017•Survey of AnesthesiologyRequires access

Sugammadex Given for Rocuronium-Induced Neuromuscular Blockade in Infants

O. Ozmete, C. Bali, O. Y. Cok, H. E. Turk, N. B. Ozyilkan, S. Civi, A. Aribogan

Abstract

(Abstracted from J Clin Anesth, 35:497–501, 2016) Sugammadex is a selective muscle relaxant binding agent with a γ-cyclodextrin structure, which reverses rocuronium- and vecuronium-induced neuromuscular blockade by chemical encapsulation. The objective of this retrospective, observational study was to evaluate the efficacy and safety of sugammadex for the reversal of profound neuromuscular blockade by rocuronium in infant patients.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Sugammadex, Rocuronium, Neuromuscular Blockade, Medicine, Blockade, Anesthesia, Muscle relaxant, Rocuronium Bromide